Skip to main content
BioNTech SE (ETR:22UA)
Germany flag Germany · Delayed Price · Currency is EUR
87.60
+0.10 (0.11%)
Last updated: Apr 16, 2025

BioNTech SE Revenue

In the year 2024, BioNTech SE had annual revenue of 2.75B EUR, down -27.96%. BioNTech SE had revenue of 1.19B in the quarter ending December 31, 2024, a decrease of -19.54%.

Revenue
2.75B
Revenue Growth
-27.96%
P/S Ratio
7.63
Revenue / Employee
406.25K
Employees
6,772
Market Cap
20.99B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.75B-1.07B-27.96%
Dec 31, 20233.82B-13.49B-77.94%
Dec 31, 202217.31B-1.67B-8.78%
Dec 31, 202118.98B18.49B3,834.63%
Dec 31, 2020482.30M373.70M344.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck KGaA 21.16B
Siemens Healthineers AG 22.67B
Fresenius SE & Co. KGaA 21.83B
Bayer Aktiengesellschaft 46.61B
Fresenius Medical Care AG 19.34B
Sartorius Aktiengesellschaft 3.38B
Carl Zeiss Meditec AG 2.08B
Fielmann Group AG 2.16B
Revenue Rankings

BioNTech SE News

More News